Pharmacist prescribing of hormonal contraceptives: Results of the Direct Access study

Journal of the American Pharmacists Association

Volumn 48, Issue 2, 2008, Pages 212-226

  Gardner, Jacqueline S ^a   Miller, Leslie ^b   Downing, Donald F ^a   Le, Stephanie ^c   Blough, David ^a   Shotorbani, Solmaz ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Meyer Pharmacies   (United States)

Author keywords

Collaborative practice; Contraceptives; Prescribers; Research

Indexed keywords

CONTRACEPTIVE AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; COOPERATION; ECONOMICS; FEMALE; FOLLOW UP; HUMAN; INTRADERMAL DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; PATIENT SATISFACTION; PHARMACIST; PHARMACY; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; UNITED STATES;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRAVAGINAL; ADULT; BLOOD PRESSURE; BODY WEIGHT; COMMUNITY PHARMACY SERVICES; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, HORMONAL; COOPERATIVE BEHAVIOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PHARMACISTS; PRACTICE GUIDELINES AS TOPIC; PROFESSIONAL ROLE; WASHINGTON;

EID: 42149164436     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2008.07138     Document Type: Article

References (15)

1. Stewart FH, Harper CC, Ellertson CE, et al. Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence. JAMA. 2001;285:2232-9.
2. Trussell J, Stewart F, Potts M, et al. Should oral contraceptives be available without prescription? Am J Public Health. 1993;83:1094-9.
3. World Health Organization. Improving access to quality care in family planning: medical eligibility criteria for contraceptive use. Geneva: World Health Organization; 2000 [WHO/RHR/00.02].
4. American College of Obstetricians and Gynecologists. ACOG practice bulletin: cervical cytology screening: number 45, August 2003. Int J Gynaecol Obstet. 2003;83:237-47.
5. Fuller TS, Christensen DB, Williams DH. Satisfaction with prescriptive authority protocols. J Am Pharm Assoc. 1996;NS36:739-45.
6. Gardner JS, Hutchings J, Fuller TS, Downing D. Increasing access to emergency contraception through community pharmacies: lessons from Washington State. Fam Plan Perspect. 2001;33:172-5.
7. Frost JJ, Singh S, Finer LB. U.S. women's one-year contraceptive use patterns, 2004. Perspect Sex Reprod Health. 2007;39:48-55.
8. Grabenstein JD, Guess HA, Hartzema AG, et al. Effect of vaccination by community pharmacists among adult prescription recipients. Med Care. 2001;39:340-8.
9. Family Health International. Reproductive health publications and materials. Accessed at www.fhi.org/en/RH/Pubs/index.htm, June 7, 2007.
10. Shotorbani S, Miller L, Blough DK, Gardner J. Agreement between women's and providers' assessment of hormonal contraceptive risk factors. Contraception. 2006;73:501-6.
11. Landau SC, Tapias MP, McGhee BT. Birth control within reach: a national survey on women's attitudes toward and interest in pharmacy access to hormonal contraception. Contraception. 2006;74:463-70.
12. Frost JJ, Singh S, Finer LB. Factors associated with contraceptive use and nonuse, United States, 2004. Perspect Sex Reprod Health. 2007;39:90-9.
13. Memmel LM, Miller L, Gardner J. Over-the-internet availability of hormonal contraceptives regardless of risk factors. Contraception. 2006;73:372-5.
14. Boseley S. Women to be able to get pill on demand at local pharmacy. The Guardian. December 13, 2007.
15. U.S. Department of Health and Human Services. Behind the counter availability of certain drugs: public meeting. Fed Regist. 2007;72:56769-70 [docket no. 2007N-0356]. Development